Trexquant Investment LP - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$3,762,162
+83.1%
157,084
+43.9%
0.10%
+76.8%
Q1 2023$2,055,088
+28.1%
109,197
+8.3%
0.06%
+24.4%
Q4 2022$1,604,545
+106.2%
100,788
+111.8%
0.04%
+66.7%
Q3 2022$778,000
-67.4%
47,580
-51.8%
0.03%
-75.9%
Q1 2022$2,388,000
+501.5%
98,612
+312.6%
0.11%
+250.0%
Q3 2021$397,000
-58.9%
23,902
-39.7%
0.03%
-61.0%
Q2 2021$967,000
-24.0%
39,634
+66.6%
0.08%
-39.3%
Q4 2020$1,272,000
+68.9%
23,797
+30.4%
0.14%
+181.2%
Q3 2020$753,000
+2.4%
18,245
+20.3%
0.05%
-5.9%
Q2 2020$735,000
-1.7%
15,168
-14.3%
0.05%
-5.6%
Q1 2020$748,000
-81.1%
17,696
-80.8%
0.05%
-76.9%
Q4 2019$3,950,000
+347.8%
92,341
+276.9%
0.23%
+207.9%
Q3 2019$882,000
+38.9%
24,497
+3.1%
0.08%
+33.3%
Q2 2019$635,000
-21.8%
23,756
-21.4%
0.06%
-1.7%
Q1 2019$812,000
+23.2%
30,237
-25.8%
0.06%
+41.5%
Q4 2018$659,000
+52.5%
40,759
+44.1%
0.04%
+36.7%
Q2 2018$432,000
-63.0%
28,281
-45.5%
0.03%
-63.0%
Q1 2018$1,167,00051,9300.08%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Baker Brothers Advisors 27,228,338$611,821,0005.19%
First Washington CORP 176,950$3,976,0002.06%
SECTORAL ASSET MANAGEMENT INC 783,424$17,604,0001.93%
HARVEY CAPITAL MANAGEMENT INC 219,042$4,921,0001.84%
Ghost Tree Capital, LLC 400,000$8,988,0001.82%
Opus Point Partners Management, LLC 36,733$825,0001.62%
Palo Alto Investors LP 1,650,780$37,093,0001.59%
EMORY UNIVERSITY 84,714$1,904,0001.36%
GARRISON BRADFORD & ASSOCIATES INC 69,000$1,550,0001.32%
HealthCor Management, L.P. 1,378,000$30,964,0001.05%
View complete list of ACADIA PHARMACEUTICALS INC shareholders